The galectin-3 level was significantly higher in the primary tumor compared to adjacent normal tissue in 55% of the well-differentiated tubular carcinoma cases and in 50% of stage III and IV tumors. The gene discussed is LGALS3; the disease is tubular adenocarcinoma.